Study examines adverse events associated with human papillomavirus vaccine
Wednesday, August 19, 2009 - 08:07
in Health & Medicine
An analysis of the adverse events reported following distribution of quadrivalent human papillomavirus recombinant vaccine since 2006 indicates that adverse event rates were consistent with pre-licensing data and expected background rates of other vaccines, with the exception of a higher proportion of reports of fainting and blood clots, according to a study in the 19 August issue of JAMA...